PatientsVille.com Logo

PatientsVille

Euglucon Side Effects

Common Euglucon Side Effects


The most commonly reported Euglucon side effects (click to view or check a box to report):

Hypoglycaemia (10)
Hypoglycaemic Coma (6)
Syncope (3)
Loss Of Consciousness (3)
Anaemia (3)
Anorexia (2)
Acute Myocardial Infarction (2)
Aplastic Anaemia (2)
Cerebral Infarction (2)
Electrocardiogram Qt Prolonged (2)
Cardiac Failure (2)
Bile Duct Obstruction (2)
Platelet Count Decreased (2)
Metabolic Acidosis (2)
Lung Disorder (2)
Myelodysplastic Syndrome (2)
Nausea (2)
Jaundice (2)
White Blood Cell Count Decreased (2)
Interstitial Lung Disease (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Euglucon Side Effects Reported to FDA

The following Euglucon reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Euglucon on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Anaemia, Hypoglycaemia
This is a report of a 80-year-old male patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Euglucon (dosage: NA, start time: Jan 01, 2008), combined with:
  • Aricept
  • Zyrtec
  • Gramalil
  • Metformin Hcl
and developed a serious reaction and side effect(s). The consumer presented with:
  • Anaemia
  • Hypoglycaemia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Euglucon treatment in male patients, resulting in anaemia side effect.

Acute Myocardial Infarction, Anorexia
This report suggests a potential Euglucon Acute Myocardial Infarction, Anorexia side effect(s) that can have serious consequences. A 66-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Euglucon (dosage: NA) starting Feb 24, 2009. Soon after starting Euglucon the patient began experiencing various side effects, including:
  • Acute Myocardial Infarction
  • Anorexia
Drugs used concurrently:
  • Avastin (Unk)
  • Fluorouracil (Unk)
  • Elplat (Unk)
  • Magnesium Oxide
  • Calcium Levofolinate (Unk)
Although Euglucon demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as acute myocardial infarction, may still occur.

Haemolytic Anaemia, Thrombocytopenia
This Haemolytic Anaemia, Thrombocytopenia problem was reported by a physician from JAPAN. A 77-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: diabetes mellitus. On Sep 26, 1991 this consumer started treatment with Euglucon (dosage: NA). The following drugs were being taken at the same time:
  • Lantus
  • Alositol
  • Glucobay
  • Cardenalin
  • Amlodipine
  • Nu-lotan
When commencing Euglucon, the patient experienced the following unwanted symptoms/side effects:
  • Haemolytic Anaemia
  • Thrombocytopenia
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as haemolytic anaemia, may become evident only after a product is in use by the general population.

Altered State Of Consciousness, Pneumonia Aspiration
This is a report of a 67-year-old female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: diabetes mellitus and was treated with Euglucon (dosage: NA) starting NS. Concurrently used drugs:
  • Basen
  • Novorapid
  • Cardenalin
  • Seloken /00376902/
  • Norvasc
  • Blopress
Soon after that, the consumer experienced the following side effects:
  • Altered State Of Consciousness
  • Pneumonia Aspiration
The patient was hospitalized. This opens a possibility that Euglucon treatment could cause the above reactions, including altered state of consciousness, and some female subjects may be more susceptible.


Acute Myocardial Infarction, Anorexia
A 66-year-old male patient (weight: NA) from JAPAN with the following symptoms/conditions: NA started Euglucon treatment (dosage: NA) on Feb 24, 2009. Soon after starting Euglucon treatment, the subject experienced various side effects, including:
  • Acute Myocardial Infarction
  • Anorexia
Concurrently used drugs:
  • Avastin (Unk)
  • Calcium Levofolinate (Unk)
  • Fluorouracil (Unk)
  • Elplat (Unk)
  • Magnesium Oxide
This finding indicates that some male patients could be more vulnerable to Euglucon.

Hypoglycaemia, Sopor
A 83-year-old male patient from ITALY (weight: NA) experienced symptoms, such as: diabetes mellitus,essential hypertension and was treated with Euglucon(dosage: NA). The treatment was initiated on Jan 01, 2008. After that a consumer reported the following side effect(s):
  • Hypoglycaemia
  • Sopor
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Euglucon efficacy:
  • Unipril /00885601/


Hypoglycaemia, Loss Of Consciousness
In this report, Euglucon was administered for the following condition: NA.A 77-year-old male consumer from ITALY (weight: NA) started Euglucon treatment (dosage: NA) on May 29, 2008.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Hypoglycaemia
  • Loss Of Consciousness
A possible interaction with other drugs could have contributed to this reaction:
  • Metforal
  • Madopar /00349201/
  • Tachipirina
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Euglucon treatment could be related to the listed above side effect(s).

Hypoglycaemic Coma
This is a report of the following Euglucon side effect(s):
  • Hypoglycaemic Coma
A 74-year-old male patient from JAPAN (weight: NA) presented with the following condition: diabetes mellitus and received a treatment with Euglucon (dosage: Dose: 2.5 Mg) starting: NS.The following concurrently used drugs could have generated interactions:
  • Lansoprazole
  • Amoxicillin
  • Clarithromycin
The patient was hospitalized.This report suggests that a Euglucon treatment could be associated with the listed above side effect(s).

Cardiac Failure, Electrocardiogram Qt Prolonged, Syncope
This Euglucon report was submitted by a 83-year-old female consumer from JAPAN (weight: NA). The patient was diagnosed with: NA and Euglucon was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Cardiac Failure
  • Electrocardiogram Qt Prolonged
  • Syncope
Other drugs used simultaneously:
  • Lanirapid
  • Losartan Potassium
  • Acetohexamide
  • Amisalin
  • Nifedipine
  • Aspirin
The patient was hospitalized.Those unexpected symptoms could be linked to a Euglucon treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Cardiac Failure, Electrocardiogram Qt Prolonged, Syncope
This is a report of a possible correlation between Euglucon use and the following symptoms/side effect(s):
  • Cardiac Failure
  • Electrocardiogram Qt Prolonged
  • Syncope
which could contribute to an assessment of Euglucon risk profile.A 83-year-old female consumer from JAPAN (weight: NA) was suffering from NA and was treated with Euglucon (dosage: NA) starting NS.Other concurrent medications:
  • Lanirapid
  • Losartan Potassium
  • Acetohexamide
  • Amisalin
  • Nifedipine
  • Aspirin
The patient was hospitalized.

Blood Glucose Decreased, Syncope
A 77-year-old male patient from ITALY (weight: NA) presented with the following symptoms: NA and after a treatment with Euglucon (dosage: NA) experienced the following side effect(s):
  • Blood Glucose Decreased
  • Syncope
The treatment was started on May 29, 2008. Euglucon was used in combination with the following drugs:
  • Metforal
  • Madopar /00349201/
  • Tachipirina
This report could alert potential Euglucon consumers.

Cerebral Infarction
In this report, a 53-year-old male patient from JAPAN (weight: NA) was affected by a possible Euglucon side effect.The patient was diagnosed with NA. After a treatment with Euglucon (dosage: NA, start date: NS), the patient experienced the following side effect(s):
  • Cerebral Infarction
The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Euglucon treatment.

Cerebral Infarction
This is a report of a 53-year-old male patient from JAPAN (weight: NA), who used Euglucon (dosage: NA) for a treatment of NA. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Cerebral Infarction
The following drugs could possibly have interacted with the Euglucon treatment NA.Taken together, these observations suggest that a Euglucon treatment could be related to side effect(s), such as Cerebral Infarction.

Anaemia, Myelodysplastic Syndrome, Platelet Count Decreased, White Blood Cell Count Decreased
This anaemia side effect was reported by a physician from JAPAN. A 81-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Euglucon (dosage: NA), which was started on NS. Concurrently used drugs: NA. When starting to take Euglucon the consumer reported the following symptoms:
  • Anaemia
  • Myelodysplastic Syndrome
  • Platelet Count Decreased
  • White Blood Cell Count Decreased
The patient was hospitalized. These side effects may potentially be related to Euglucon.

Anaemia, Myelodysplastic Syndrome, Platelet Count Decreased, White Blood Cell Count Decreased
This is a Euglucon side effect report of a 81-year-old male patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Euglucon (dosage:NA, start time: NS), combined with: NA., and developed a serious reaction and a anaemia side effect. The patient presented with:
  • Anaemia
  • Myelodysplastic Syndrome
  • Platelet Count Decreased
  • White Blood Cell Count Decreased
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Euglucon treatment in male patients suffering from NA, resulting in anaemia.

Accidental Exposure, Hypoglycaemia
This report suggests a potential Euglucon accidental exposure side effect(s) that can have serious consequences. A 70-year-old male patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): NA and used Euglucon (dosage: NA) starting Apr 16, 2007. Soon after starting Euglucon the patient began experiencing various side effects, including:
  • Accidental Exposure
  • Hypoglycaemia
Drugs used concurrently:
  • Glucose (Dose: Unk)
Although Euglucon demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as accidental exposure, may still occur.

Hallucination
This hallucination problem was reported by a physician from JAPAN. A 77-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Mar 18, 2007 a consumer started treatment with Euglucon (dosage: Dose: Unk). The following drugs/medications were being taken at the same time:
  • Tamiflu
  • Norvasc (Dose: Unk)
  • Diovan (Dose: Unk)
  • Hokunalin
  • Famotidine (Dose: Unk)
  • Theo-dur (Dose: Unk)
  • Fluticasone Propionate (Dose: Unk)
  • Actos (Dose: Unk)
When commencing Euglucon, the patient experienced the following unwanted symptoms /side effects:
  • Hallucination
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as hallucination, may become evident only after a product is in use by the general population.

Convulsion, Hypoglycaemic Coma
This is a Euglucon side effect report of a 84-year-old female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: diabetes mellitus and was treated with Euglucon (dosage: NA) starting NS. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Convulsion
  • Hypoglycaemic Coma
The patient was hospitalized. This opens a possibility that Euglucon could cause convulsion and that some female patients may be more susceptible.

Hypoglycaemia, Hypoglycaemic Coma
A 85-year-old female patient (weight: NA) from JAPAN with the following symptoms: diabetes mellitus started Euglucon treatment (dosage: NA) on Jul 27, 2000. Soon after starting Euglucon treatment, the consumer experienced several side effects, including:
  • Hypoglycaemia
  • Hypoglycaemic Coma
. Concurrently used drugs:
  • Calblock
  • Enalapril Maleate
  • Voglibose
  • Terazosin Hcl
  • Metformin Hcl
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Euglucon side effects, such as hypoglycaemia.

Cardio-respiratory Arrest, Hypoglycaemic Coma, Pulmonary Embolism
This cardio-respiratory arrest side effect was reported by a consumer or non-health professional from JAPAN. A 81-year-old female patient (weight:NA) experienced the following symptoms/conditions: diabetes mellitus non-insulin-dependent.The patient was prescribed Euglucon (dosage: NA), which was started on NS. Concurrently used drugs:
  • Pioglitazone Hcl
.When starting to take Euglucon the consumer reported symptoms, such as:
  • Cardio-respiratory Arrest
  • Hypoglycaemic Coma
  • Pulmonary Embolism
These side effects may potentially be related to Euglucon. The patient was hospitalized.

Hypoglycaemia, Muscle Spasms, Muscle Twitching, Nausea
This is a report of a 85-year-old female patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: diabetes mellitus, who was treated with Euglucon (dosage: NA, start time: Jul 27, 2000), combined with:
  • Calblock
  • Enalapril Maleate
  • Voglibose
  • Terazosin Hcl
  • Metformin Hcl
and developed a serious reaction and side effect(s). The consumer presented with:
  • Hypoglycaemia
  • Muscle Spasms
  • Muscle Twitching
  • Nausea
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Euglucon treatment in female patients, resulting in hypoglycaemia side effect. The patient was hospitalized.

Hypoglycaemia, Hypoglycaemic Coma, Loss Of Consciousness
This report suggests a potential Euglucon Hypoglycaemia, Hypoglycaemic Coma, Loss Of Consciousness side effect(s) that can have serious consequences. A 85-year-old female patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Euglucon (dosage: NA) starting NS. Soon after starting Euglucon the patient began experiencing various side effects, including:
  • Hypoglycaemia
  • Hypoglycaemic Coma
  • Loss Of Consciousness
Drugs used concurrently: NA.The patient was hospitalized. Although Euglucon demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hypoglycaemia, may still occur.

Acidosis, Hypoglycaemia
This Acidosis, Hypoglycaemia problem was reported by a consumer or non-health professional from . A 65-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: diabetes mellitus. On NS this consumer started treatment with Euglucon (dosage: NA). The following drugs were being taken at the same time:
  • Dianben
  • Doneka Plus
  • Adiro
  • Emconcor
  • Pantok
When commencing Euglucon, the patient experienced the following unwanted symptoms/side effects:
  • Acidosis
  • Hypoglycaemia
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as acidosis, may become evident only after a product is in use by the general population.

Coordination Abnormal, Tremor
This is a report of a 91-year-old male patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: diabetes mellitus non-insulin-dependent and was treated with Euglucon (dosage: NA) starting NS. Concurrently used drugs:
  • Actos (Dose: Not Reported)
Soon after that, the consumer experienced the following side effects:
  • Coordination Abnormal
  • Tremor
The patient was hospitalized. This opens a possibility that Euglucon treatment could cause the above reactions, including coordination abnormal, and some male subjects may be more susceptible.

Blood Pressure Diastolic Increased, Glycosylated Haemoglobin Increased, Hypoglycaemic Coma, Lactic Acidosis, Overdose, Renal Failure, Respiratory Rate Increased
A 67-year-old male patient (weight: NA) from JAPAN with the following symptoms/conditions: diabetes mellitus non-insulin-dependent started Euglucon treatment (dosage: NA) on NS. Soon after starting Euglucon treatment, the subject experienced various side effects, including:
  • Blood Pressure Diastolic Increased
  • Glycosylated Haemoglobin Increased
  • Hypoglycaemic Coma
  • Lactic Acidosis
  • Overdose
  • Renal Failure
  • Respiratory Rate Increased
Concurrently used drugs:
  • Metformin Hcl
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Euglucon.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Euglucon Side Effects

    Did You Have a Euglucon Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Euglucon for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Euglucon Safety Alerts, Active Ingredients, Usage Information

    More About Euglucon

    Side Effects reported to FDA: 40

    Euglucon safety alerts: No

    Reported deaths: 3

    Reported hospitalizations: 24

    Latest Euglucon clinical trials